Search

The Good Outcome Following Attempted Resuscitation (GO-FAR) Score uses pre-arrest factors to predict survival after In-Hospital Cardiac Arrest (IHCA) with minimal neurological dysfunction, (cerebral performance category (CPC) ≤1). Moderate neurological dysfunction (CPC ≤2) may be a more acceptable outcome.To predict survival after IHCA with mild or moderate neurological dysfunction based on pre-arrest factors.52,468 patients with IHCA from 2012-2017. Data was divided into training (44%), testing (22%), and validation (34%) sets. Univariate analysis was used to identify variables with3% difference in survival with CPC ≤2. These variables carried forward to the multivariate logistic regression model. The most parsimonious model that best classified patients as having a very poor (≤5%), below average (≤10%), average (11%-30%), or above average (30%) likelihood of survival with CPC ≤2 was chosen.Age85, admission CPC2, and non-surgical admission were strongly association with poor survival (-12.1%, -14.4%, and -18%, respectively). Nine variables were included in the logistic regression analysis. The final updated model, GO FAR 2, categorized 6.2% of patients with a very poor predicted survival, 24.8% of patients with a below average predicted survival, and 11.3% with above average predicted survival. The observed survival among those with very poor predicted survival was 4.5%.The GO FAR 2 score provides clinicians with a prognostic estimate of the likelihood of a good outcome after IHCA based on pre-arrest patient factors. Future research is required to validate the GO-FAR 2 score.

Aim We aimed to prospectively validate the Good Outcome Following Attempted Resuscitation (GO-FAR) score, which predicts the likelihood of survival to discharge neurologically intact or with minimal deficits (conscious, alert, and able to work) after in-hospital cardiac arrest (IHCA). Methods Inpatients experiencing an index episode of IHCA between 2010 and 2016 in hospitals participating in the Get With the Guidelines® — Resuscitation (GWTG-R) Registry were included. The score’s performance was prospectively validated in both all GWTG-R hospitals and in a subset of hospitals not part of the GWTG-R registry when the score was originally developed using prospective data. Score performance was stratified by hospital size, presence of residency training programs, and type of hospital ownership. Discrimination was measured by the c-statistic, calibration using a Hosmer-Lemeshow plot, and classification accuracy by the survival rates in each risk group. Results A total of 62,131 inpatients in 386 hospital were included. The GO-FAR score had similar discrimination (c-statistic 0.75, 95% CI 0.748−0.758), calibration, and classification accuracy as in the original study. Survival rates were somewhat higher due to a secular increase in survival of IHCA. In hospitals that were not part of the derivation population, the score performed as well as in the hospitals used to derive the score (c-statistic 0.75). The score performed similarly in hospitals of different sizes (c-statistic of 0.80 and 0.75 for hospital with ≤100 and >100 beds, respectively), with and without residency training programs (c-statistics of 0.76 and 0.75, respectively), and with different ownership structures (c-statistic of 0.79 for private, 0.74 for military government, and 0.76 for nonprofit hospital). Conclusions The GO-FAR score accurately classifies patients into risk groups based on their likelihood of survival to discharge with a good neurologic outcome following an episode of IHCA. Recalibration may be necessary using different point score cutoffs as IHCA survival increases.